Praxis precision medicines to present at piper sandler's 33rd annual virtual healthcare conference

Boston, nov. 24, 2021 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal imbalance, today announced that management will participate in a fireside chat at piper sandler's 33rd annual virtual healthcare conference on thursday, december 2, 2021 at 10:30 a.m. et.
PRAX Ratings Summary
PRAX Quant Ranking